More than 85,000 infants and toddlers diagnosed with RSV in 2024 ahead of national vaccine rollout
More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.
Hosted on MSN3h
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...
Urgent 'stay home' and 'wear mask' warning as infections spread
Flu is a viral infection affecting the nose, throat and lungs, mostly during the winter months. It is far worse than an ...
Armed robbery in Revesby9h
One-Third of Birthing Women Get RSV Vaccine in First Month
Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory ...
Everything we know about HMPV in the UK: Symptoms, case numbers and how to get a test
But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory illness increased to 4.92 per cent by the middle of January 2025. This is ...
'Stay home and mask up' plea issued over barrage of winter bugs
Moving on to the common cold, caused by the rhinovirus, the UKHSA explains that symptoms develop gradually over a few days.